Lack of access to effective treatments is forcing blood cancer patients to take desperate measures 12 April 2018 Lack of funded access to life-extending treatments for multiple myeloma is causing some New Zealand patients to take desperate measures, including importing cheap, potentially less effective ‘knock-offs’ of the drug Lenalidomide from India, and in some cases...Continue Reading
The IMF is very pleased to have established a partnership with AbbVie to conduct the largest, most comprehensive chart-review study of myeloma patients with the t(11;14) translocation evident on FISH (fluorescence in situ hybridization) testing of bone marrow myeloma cells. This landmark retrospective analysis assesses the 16-to-24-percent of myeloma patients harboring the t(11;14) translocation. The...Continue Reading
Multiple Myeloma action month March 2018: Thanks to medical innovation, Multiple Myeloma patients are living longer than ever before. Multiple Myeloma (MM) is the second most commonly diagnosed blood cancer after non-Hodgkin lymphoma, yet few people know much about this deadly disease. The American Cancer Society’s estimates for multiple myeloma in the United States for...Continue Reading
What’s New in Myeloma Treatment: a New Zealand Perspective Dr. Leanne Berkahn, Dr. Henry Chan, Dr. Phillip Insull, and Dr. David Simpson, spoke at our patient seminar on What’s New in Myeloma Treatment: a New Zealand Perspective. Watch the seminar here: Continue Reading
Improving Survival in Multiple Myeloma Dr. Henry Chan from North Shore Hospital spoke at our patient seminar on his recent work looking at multiple myeloma incidence and survival outcomes in New Zealand. Dr Chan has just delivered a paper on this at the Haematology Society of Australia and NZ’s annual scientific conference. Download the presentation...Continue Reading
Issue 25 of Multiple Myeloma Research Review. Highlights include: Induction VCD. Prediction of outcome in newly diagnosed myeloma Final analysis of survival in the FIRST trial in MM. Daratumumab + VMP for untreated myeloma. Download hereContinue Reading
The Cancer Society is calling for major changes to cancer services to save lives. It says 2,500 more New Zealanders would have survived cancer if they’d lived across the ditch. The claim is based on cancer survival statistics in a new international report published last month in the Lancet. It shows the chances of surviving...Continue Reading
Happy New Year & greetings to you all Patient seminars: save the date Auckland on 28 February at North Shore Hospital Auditorium Wellington on 8 March at Russell McVeagh, Data Dimension House Click here or visit our Facebook page for details. I’m delighted that Dr Robert Weinkove from CCDHB and the Malaghan Research Institute has...Continue Reading
Greetings SAVE THE DATE: Patient Seminar 29 November, 5:30 – 7.30pm I’m delighted to advise that Dr Henry Chan from North Shore Hospital has agreed to come and speak to us on his recent work looking at multiple myeloma incidence and survival outcomes in New Zealand. Dr Chan has just delivered a paper on this...Continue Reading
Welcome to the first newsletter from Myeloma New Zealand. Setting up a new entity from scratch was always going to take time but we have made significant strides over the last month and I am pleased to report on them. I want to emphasise that we are determined to make this a patient-focused, patient-driven organisation...Continue Reading
